Zhang, Kai
Sakamoto, Akemi
Chang, Lijia
Qu, Youge
Wang, Siming
Pu, Yaoyu
Tan, Yunfei
Wang, Xingming
Fujita, Yuko
Ishima, Tamaki
Hatano, Masahiko
Hashimoto, Kenji http://orcid.org/0000-0002-8892-0439
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19dm0107119)
Japan Society for the Promotion of Science (19K17054)
Article History
Received: 8 November 2019
Accepted: 17 December 2019
First Online: 24 December 2019
Compliance with ethical standards
:
: Dr. Hashimoto is an inventor on the filed patent on “The use of (<i>R</i>)-ketamine in the treatment of psychiatric diseases”. Other authors declare no conflict of interest.